In focus · trending topic

akt inhibitor

4 stories · following the connections

ArQule Reports Fourth Quarter and Full Year 2015 Financial Results

By Nasdaq OMXFeb 29, 2016, 12:00 PM UTC

ArQule Announces $15.3 Million Registered Direct Offering of Common Stock

By Nasdaq OMXFeb 29, 2016, 11:55 AM UTC

ArQule to Present at Upcoming Investor Conferences

By Nasdaq OMXFeb 4, 2016, 12:30 PM UTC

ArQule Provides Proprietary Pipeline Update for AKT Inhibitors

By Nasdaq OMXJan 28, 2016, 12:30 PM UTC